These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 22261333
1. Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically. Zapotocky M, Mejstrikova E, Smetana K, Stary J, Trka J, Starkova J. Cancer Lett; 2012 Jun 28; 319(2):144-153. PubMed ID: 22261333 [Abstract] [Full Text] [Related]
5. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation. Liu J, Lu W, Liu S, Wang Y, Li S, Xu Y, Xing H, Tang K, Tian Z, Rao Q, Wang M, Wang J. Leuk Res; 2018 May 28; 68():15-21. PubMed ID: 29518627 [Abstract] [Full Text] [Related]
6. Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells. Trombly DJ, Whitfield TW, Padmanabhan S, Gordon JA, Lian JB, van Wijnen AJ, Zaidi SK, Stein JL, Stein GS. BMC Genomics; 2015 Apr 17; 16(1):309. PubMed ID: 25928846 [Abstract] [Full Text] [Related]
8. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia. Fu L, Huang W, Jing Y, Jiang M, Zhao Y, Shi J, Huang S, Xue X, Zhang Q, Tang J, Dou L, Wang L, Nervi C, Li Y, Yu L. FEBS J; 2014 Feb 17; 281(4):1123-31. PubMed ID: 24314118 [Abstract] [Full Text] [Related]
9. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner. Elsässer A, Franzen M, Kohlmann A, Weisser M, Schnittger S, Schoch C, Reddy VA, Burel S, Zhang DE, Ueffing M, Tenen DG, Hiddemann W, Behre G. Oncogene; 2003 Aug 28; 22(36):5646-57. PubMed ID: 12944913 [Abstract] [Full Text] [Related]
11. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G. Blood; 2003 Jan 01; 101(1):270-7. PubMed ID: 12393465 [Abstract] [Full Text] [Related]
12. Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia. Li Y, Wang H, Wang X, Jin W, Tan Y, Fang H, Chen S, Chen Z, Wang K. Blood; 2016 Jan 14; 127(2):233-42. PubMed ID: 26546158 [Abstract] [Full Text] [Related]
13. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells. Zaidi SK, Perez AW, White ES, Lian JB, Stein JL, Stein GS. Oncotarget; 2017 Jun 20; 8(25):39994-40005. PubMed ID: 28611288 [Abstract] [Full Text] [Related]
17. Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemia. Le XF, Claxton D, Kornblau S, Fan YH, Mu ZM, Chang KS. Eur J Haematol; 1998 Apr 20; 60(4):217-25. PubMed ID: 9579874 [Abstract] [Full Text] [Related]
18. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia. Jin W, Wu K, Li YZ, Yang WT, Zou B, Zhang F, Zhang J, Wang KK. Oncogene; 2013 Apr 11; 32(15):1978-87. PubMed ID: 22641217 [Abstract] [Full Text] [Related]